02/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

02/2025

Feb 5, 2025, 00:00 | Science
Elvina Almuradova: PTC significantly prolongs OS in patients with HER2+ metastatic breast cancer
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn about…
Feb 4, 2025, 23:58 | Blog
Emad Shash: Enhancing sustainable development in Egypt through scientific research and innovation
Emad Shash, Leading Cancer Researcher and Manager at National Cancer Institute, Cairo University, shared a…
Feb 4, 2025, 23:57 | Blog
Wafaa Rashed: Your Voice Matters in Shaping Maternal-Fetal Genomics Policy
Wafaa Rashed, Chair and Founder of PAPERI, shared a post on LinkedIn: "New Video Alert:…
Feb 4, 2025, 23:30 | Blog
E. Shyam P. Reddy: How cancer ‘poisons’ the immune system
E. Shyam P. Reddy, Professor and Director of Cancer Biology Program, Department of OB/GYN at…
Feb 4, 2025, 23:29 | Blog
Todd Harper: Cancer changes lives, it turns lives upside down
Todd Harper, CEO at Cancer Council Victoria, shared a post on LinkedIn: “Every cancer experience…
Feb 4, 2025, 22:36 | Blog
Nina Niu Sanford: An overview of GI radiation oncology
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s…
Feb 4, 2025, 22:33 | Science
Opioid use among hospitalized patients with cancer pain
ACS Journal Cancer shared an article led by Joseph A. Arthur on X about the…
Feb 4, 2025, 22:31 | Blog
Rachit Khandelwal: Targeting CD47 - many misses, hopeful for a hit
Rachit Khandelwal, Pediatrics BMT fellow at Medanta The Medicity, Gurgaon, shared a post on X: "Targeting…
Feb 4, 2025, 21:34 | Science
Erman Akkus: Treatment of dMMR/MSI gastro-oesophageal adenocarcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about recent…
Feb 4, 2025, 21:28 | Blog
Susan Galbraith: Each person’s treatment needs to be personal
Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared a post on LinkedIn:…
All: 2086 Posts: 1681 - 1690
Special Coverage